Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
ACWI ex JAPAN ex CHINA A 2022 May SAIR Constituent
新型コロナウイルス感染症に関する 国内外の研究開発動向について
新型コロナウイルス感染症に関する 国内外の研究開発動向について
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain | bioRxiv
Easy & Reliable – Biomedica´s Cytokine ELISA Kits | Biomedica
An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use | ACS Nano
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Rapid characterization of spike variants via mammalian cell surface display | bioRxiv
Cancers | Free Full-Text | STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy | HTML
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
新型コロナウイルス感染症に関する 国内外の研究開発動向について
